EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population

Berbang Meshko iD, Thomas L A Volatier iD, Johanna Mann iD, Mark A Kluth iD, Christoph Ganss, Markus H Frank iD, Natasha Y Frank, Bruce R Ksander, Claus Cursiefen iD, Maria Notara

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Berbang Meshko und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Vascular Endothelial Growth Factor A, ATP Binding Cassette Transporter, Subfamily B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIA NIH HHS, DFG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Corneal transparency and avascularity are essential for vision. The avascular cornea transitions into the vascularized conjunctiva at the limbus. Here, we explore a limbal stromal cell sub-population that expresses ABCB5 and has mesenchymal stem cell characteristics. Human primary corneal stromal cells were enriched for ABCB5 by using FACS sorting. ABCB5+ cells expressed the MSC markers CD90, CD73, and CD105. ABCB5+ but not ABCB5− cells from the same donor displayed evidence of pluripotency with a significantly higher colony-forming efficiency and the ability of trilineage differentiation (osteogenic, adipogenic, and chondrogenic). The ABCB5+ cell secretome demonstrated lower levels of the pro-inflammatory protein MIF (macrophage migration inhibitory factor) as well as of the pro-(lymph)angiogenic growth factors VEGFA and VEGFC, which correlated with reduced proliferation of Jurkat cells co-cultured with ABCB5+ cells and decreased proliferation of blood and lymphatic endothelial cells cultured in ABCB5+ cell-conditioned media. These data support the hypothesis that ABCB5+ limbal stromal cells are a putative MSC population with potential anti-inflammatory and anti-(lymph)angiogenic effects. The therapeutic modulation of ABCB5+ limbal stromal cells may prevent cornea neovascularization and inflammation and, if transplanted to other sites in the body, provide similar protective properties to other tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsVascular Endothelial Growth Factor AATP Binding Cassette Transporter, Subfamily BHumansCell DifferentiationVascular Endothelial Growth Factor CCell ProliferationLimbus CorneaeATP Binding Cassette Transporter, Subfamily B, Member 1Jurkat CellsCells, CulturedStromal CellsCoculture TechniquesEndothelial Cells

Stichwörter der Autor:innen

(lymph)angiogenesisABCB5corneamesenchymal stem cells

Substanzen

ABCB5 protein, humanVascular Endothelial Growth Factor AATP Binding Cassette Transporter, Subfamily BVascular Endothelial Growth Factor CATP Binding Cassette Transporter, Subfamily B, Member 1VEGFC protein, humanVEGFA protein, human

Autor:innen und Institutionen

  • Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
  • RHEACELL GmbH & Co. KG, Im Neuenheimer Feld 517, 69120 Heidelberg, Germany.
  • Transplant Research Program, Boston Children's Hospital, Boston, MA 02115, USA.
  • Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.
  • School of Medical and Health Sciences, Edith Cowan University, Perth, WA 6027, Australia.

ORCID-Profile: Berbang Meshko, Thomas L A Volatier, Johanna Mann, Mark A Kluth, Markus H Frank, Claus Cursiefen

Förderung

  • NEI NIH HHS
  • NIA NIH HHS
  • DFG
  • NHLBI NIH HHS
  • EU COST
  • DFG SFB 1607/1 2024
  • EU Horizon 2020 Arrest Blindness
  • EU Restore Vision

Zitieren

APA

Meshko, B., Volatier, T. L. A., Mann, J., Kluth, M. A., Ganss, C., Frank, M. H., Frank, N. Y., Ksander, B. R., Cursiefen, C., & Notara, M. (2024). Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179702

Vancouver

Meshko B, Volatier TLA, Mann J, Kluth MA, Ganss C, Frank MH, et al. Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179702

BibTeX
@article{Meshko2024,
  author = {Meshko, Berbang and Volatier, Thomas L A and Mann, Johanna and Kluth, Mark A and Ganss, Christoph and Frank, Markus H and Frank, Natasha Y and Ksander, Bruce R and Cursiefen, Claus and Notara, Maria},
  title = {Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179702}
}
Kostenlos starten →